About Centurion Remedies Private Limited
Data last updated:
Centurion Remedies Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 April 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2003PTC042254. Its GSTIN is 24AACCC2276P1ZF (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹47.5 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Dipakkumar Kantibhai Patel and Mahipat Ambalalbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G / 5 Industrial Estate Gorwa, Vadodara, Gujarat, India – 390016.
As per the financials filed for FY 2025, the company reported a revenue of ₹128.35 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹68.5 Lakh (net margin 0.5%) and EBITDA of ₹7.44 Cr (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 7% over five years.
The company has about 273 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹46.05 Cr and satisfied charges of ₹114.37 Cr on record. Court records list 37 cases involving the company, including 22 filed by the company and 15 filed against it; 17 cases are pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.91 Cr; the latest was in June 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 3 smaller; the largest is Prosperity Drugs Private Limited with revenue of ₹131.43 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 19 overdue payments to 5 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website centurionremedies.net.
Company details
Contact details
Centurion Remedies Private Limited's registered office is in Vadodara, Gujarat. Its website is centurionremedies.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressG / 5 Industrial Estate Gorwa, Vadodara, Gujarat, India – 390016
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Centurion Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Centurion Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Centurion Remedies Private Limited, buy the company report.
Financials of Centurion Remedies Private Limited
FY 2025 filings availableCenturion Remedies Private Limited reported revenue of ₹128.35 Cr (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Centurion Remedies Private Limited, buy the company report.
Board of directors of Centurion Remedies Private Limited
Centurion Remedies has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipakkumar Kantibhai Patel | Director | 12 Nov 2024 | 1 Years 11 Months | Current |
| Mahipat Ambalalbhai Patel Also directs: Curventis Laboratories LLP, Centurion Research Private Limited, Centurion Laboratories Private Limited and 1 more | Director | 30 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Centurion Remedies Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prosperity Drugs Private Limited | ₹131.43 Cr (FY 2025) | -1.0% | Solan, Himachal Pradesh, India | |||
| Dey's Medical Stores (Manufacturing) Ltd | ₹130.35 Cr (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Elder Prroject Limited | ₹129.37 Cr (FY 2022) | 18.0% | Mumbai, Maharashtra, India | |||
| Maxim Pharmaceuticals Private Limited | ₹129.31 Cr (FY 2025) | -6.0% | Pune, Maharashtra, India | |||
| Koye Pharmaceuticals Private Limited | ₹129.09 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Centurion Remedies Private Limitedthis company | ₹128.35 Cr (FY 2025) | ₹68.5 Lakh | 0.5% | -10.0% | 273 | Vadodara, Gujarat, India |
| Encore Healthcare Private Limited | ₹128.04 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Super Formulations Private Limited | ₹123.88 Cr (FY 2024) | 17.0% | Ujjain, Madhya Pradesh, India | |||
| Rubicon Formulations Private Limited | ₹123.25 Cr (FY 2025) | 29.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Centurion Remedies Private Limited, buy the company report.
Auditor
Centurion Remedies Private Limited is audited by Surti & Talati for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Surti & Talati | FY 2024 | 114924W |
Shareholding
The shareholding of Centurion Remedies Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Centurion Remedies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jun 2026 | 101317929 | Hdfc Bank Limited | ₹3.93 Cr | Open | |
| 22 Jan 2025 | 101044140 | Others | ₹38.5 Lakh | Open | |
| 22 Jan 2025 | 101044141 | Others | ₹37.5 Lakh | Open | |
| 06 Jun 2024 | 100942545 | Hdfc Bank Limited | ₹39.71 Cr | Open | |
| 26 Jul 2022 | 100602252 | Others | ₹42.12 Lakh | Open |
To see the full charge records of Centurion Remedies Private Limited, buy the company report.
Total charge records: 26 View all charges
Deals & funding
Centurion Remedies Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.91 Cr; the latest was in June 2024.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Jan 2012 | Funding round | ₹3.12 Cr | Investors: Amabalal Vanarasidas Patel HUF, 3 individuals |
| Mar 2010 | Funding round | ₹78.7 Lakh | Investors: Amabalal Vanarasidas Patel HUF, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Centurion Remedies Private Limited has 37 court cases on record: 22 filed by Centurion Remedies, 15 filed against it. 17 cases are pending and 20 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 24 | 4 | 11 |
| District courts | 12 | 11 | 6 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 37)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by STG Pharmagenerics Pvt Ltd Through Its Authorised Representative Mr Errol Silvapinto | Pending |
| Patna High Court | Court case (CWJC) | Filed by the company against Bihar Medical Services and Infrastructure Corporation Ltd., and 3 others | Disposed |
| District court, Vadodara, Gujarat | Commercial matter | Filed against the company by Novartis Healthcare Pvt. Ltd. and 1 other | Disposed |
| Supreme Court | Court case (4202-MATTERS RELATING TO LEASES, GOVT. CONTRACTS & CONTRACTS BY LOCAL BODIES : Tenders invited or contracts awarded/leases granted or determined by public sector undertaking) | Filed by the company against Gujarat Medical Services Corporation Ltd. Managing Director Managing Director Block No. 14/1, Dr. Jivraj Mehta Bhavan, Old Sachivalaya, , District: Gandhi Nagar ,Gandhinagar , Gujarat | Disposed |
| District court, Lohit, Arunachal Pradesh | Revision petition | Filed against the company by Union of India | Pending |
To see the full case history of Centurion Remedies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Centurion Remedies Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 19 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Standhardt Innovations | |||
| Mehta Pharmaceutical Industries | |||
| Atharva Packaging Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Centurion Remedies Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Centurion Remedies Private Limited has a workforce of 273 employees on its EPFO records as of Dec 08, 2025, across 2 active EPFO establishments.
GST
Centurion Remedies has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCC2276P1ZF | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Centurion Remedies Private Limited, buy the company report.
Recent activity
Centurion Remedies Private Limited has 11 board changes on record since 2008: 2 appointments and 9 cessations. The latest: Priyanshi Patel ceased to be Director on 05 Dec 2024.
51 earlier events are in the company report.
Frequently asked questions
Centurion Remedies is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 April 2003 (23+ years old) and is registered under CIN U24231GJ2003PTC042254.
Centurion Remedies has 2 current directors:
- Dipakkumar Kantibhai Patel - Director
- Mahipat Ambalalbhai Patel - Director
The latest financial statements of Centurion Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Centurion Remedies is 24AACCC2276P1ZF, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Centurion Remedies is U24231GJ2003PTC042254. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Centurion Remedies has 37 court cases on record: 22 filed by the company and 15 filed against it. 17 are pending. Most are in the high courts.
Centurion Remedies was incorporated on 21 April 2003, making it 23+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Centurion Remedies has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.91 Cr; the latest was in June 2024.
The peers of Centurion Remedies by revenue are Prosperity Drugs Private Limited, Dey's Medical Stores (Manufacturing) Ltd, Elder Prroject Limited, Maxim Pharmaceuticals Private Limited, Koye Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Priyanshi Patel ceased to be Director on 05 Dec 2024. Mahipat Ambalalbhai Patel was appointed as Director on 30 Nov 2024. Dipakkumar Kantibhai Patel was appointed as Director on 12 Nov 2024. Centurion Remedies has 11 board changes on record in total.
Centurion Remedies has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 19 overdue payments to 5 micro and small suppliers. The latest return was filed on 08 Jun 2019.
Centurion Remedies can be reached through the website centurionremedies.net. Its registered office is in Vadodara, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
